Latest Media Releases

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

ImpediMed Announces End Stage Renal Disease Trial Agreement (ASX:IPD)

ImpediMed Limited (ASX.IPD) is pleased to announce it has entered into an agreement with balboa RESEARCH SMO+ (“Balboa”) and Frenova Renal Research, a Fresenius Medical Care Company, to ...read more

ImpediMed - PREVENT Trial Peer-Reviewed and Published (ASX:IPD)

ImpediMed Limited (ASX.IPD) is pleased to announce the PREVENT Trial results have been peer-reviewed and published in Lymphatic Research and Biology, a journal dedicated to research on lymphatic bio...read more

ImpediMed - Appendix 4C & Quarterly Activities Report (ASX:IPD)

Robust results -- Robust quarter despite meaningful impact from Omicron variant -- Record results in Q2 FY’22 for SOZO®SaaS revenue -- $50.8m cash balance and fully funded to cashflow...read more

ImpediMed - Share Purchase Plan Successfully Completed (ASX:IPD)

ImpediMed Limited (ImpediMed or the Company) (ASX:IPD) is pleased to announce the successful completion of its Share Purchase Plan (SPP). The SPP closed on Thursday, 12 November 2021 heavily oversub...read more

ImpediMed - Application for quotation of securities (ASX:IPD)

To view the Application for quotation of +securities, download the attached PDF.

ImpediMed - Amendments to Constitution (ASX:IPD)

ImpediMed Limited (ImpediMed) (ASX:IPD) advises that amendments to its Constitution were approved by a special resolution of shareholders at the Company’s Annual General Meeting held on 10 Nov...read more

ImpediMed - Results of Meeting (ASX:IPD)

Set out below are the results of the 2021 Annual General Meeting (AGM) held earlier today. All resolutions put to the AGM were decided by a poll. For more information, download the attached PDF. ...read more

ImpediMed - 2021 Annual General Meeting - Chairman's Address (ASX:IPD)

So welcome and thank you for joining us today. I hope that all of you and your families are healthy and are continuing to successfully navigate this pandemic. As I begin my prepared remarks, I wo...read more

ImpediMed - AGM Presentation - November 2021 (ASX:IPD)

ImpediMed Limited (ImpediMed) (ASX: IPD) provides the attached CEO’s presentation to be delivered at today’s Annual General Meeting commencing at 9.00am AEDT. The webcast of the AGM c...read more

ImpediMed - AstraZeneca extends and increases HF & Renal Contract (ASX:IPD)

Key Highlights AstraZeneca extends its contract for the Phase IIb trial, which is utilising SOZO® to measure fluid volume in patients with heart failure and chronic kidney disease, by 3 mont...read more

ImpediMed - Share Purchase Plan Offer Booklet (ASX:IPD)

You should read this Booklet in full. Eligible Shareholders have the opportunity to participate in the Share Purchase Plan offer by applying for up to $30,000 of new Shares without incurring brokera...read more

ImpediMed's Share Purchase Plan Opens (ASX:IPD)

The Share Purchase Plan (SPP) announced by ImpediMed Limited (ImpediMed or the Company) (ASX: IPD) on Wednesday, 27 October 2021 opens today. Eligible Shareholders in Australia and New Zealand now h...read more

ImpediMed - Appendix 4C & Quarterly Activities Report (ASX:IPD)

ImpediMed Limited (ASX.IPD) today released its Appendix 4C – Quarterly Cash Flow report for the period ended 30 September 2021. A summary of the quarterly results was released on 27 October 20...read more

ImpediMed Completes A$35 Million Institutional Placement (ASX:IPD)

ImpediMed Limited (ImpediMed or the Company) is pleased to announce that it has received firm commitments to raise A$35m (before costs) by the way of institutional placement to support product, data...read more

ImpediMed - Trading Halt (ASX:IPD)

The securities of Impedimed Limited (‘IPD’) will be placed in trading halt at the request of IPD, pending it releasing an announcement. Unless ASX decides otherwise, the securities will ...read more

Viewing: 16 - 30 of 41 Previous | Next